Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Articles / Jan / What's Next
Manufacture Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Biopharma

What's Next

Exploring the Future of Bioprocessing Together.

01/03/2018 1 min read

Share

What actually is next generation bioprocessing? How are industry players defining next generation bioprocessing and how will they pursue and successfully implement this approach? And is continuous bioprocessing always the ultimate end goal drug manufacturers around the globe are, or should be, striving for? In this dedicated supplement, experts from both biologics manufacturers and from Merck provide their insights and perspectives on the on-going paradigm shift towards next generation bioprocessing occurring in today’s and tomorrow’s biopharma landscape.

Download the eBook here

What actually is next generation bioprocessing? How are industry players defining next generation bioprocessing and how will they pursue and successfully implement this approach? And is continuous bioprocessing always the ultimate end goal drug manufacturers around the globe are, or should be, striving for? In this dedicated supplement, experts from both biologics manufacturers and from MilliporeSigma provide their insights and perspectives on the on-going paradigm shift towards next generation bioprocessing occurring in today’s and tomorrow’s biopharma landscape.

Download the eBook here

List of articles

Welcome to the Next Generation of Bioprocessing

Facing the future

The Connected Process

Putting Single-Pass Tangential Flow Filtration (SPTFF) into Place

Perfecting Perfusion

New Horizons

Mastering Continuous Biomanufacturing

List of articles

Welcome to the Next Generation of Bioprocessing

Facing the future

The Connected Process

Putting Single-Pass Tangential Flow Filtration (SPTFF) into Place

Perfecting Perfusion

New Horizons

Mastering Continuous Biomanufacturing

Download the eBook here

Download the eBook here

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

AI Approach to Transdermal GLP-1s
Advanced Medicine Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Dosage Forms Contract Manufacturing Services Biosimilars Packaging Process Control Supply Chain Quality & Compliance
AI Approach to Transdermal GLP-1s

February 25, 2025

3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

ADCs: When Bioprocessing Becomes Toxic
Bioprocessing - Single Use Systems
ADCs: When Bioprocessing Becomes Toxic

January 31, 2025

3 min read

Doing more to ease the challenges of antibody drug conjugate manufacturing.

FDA or EMA Novel Drug Approvals 2024: Anagrams Edition
Advanced Medicine Bioprocessing - Single Use Systems Small Molecules Standards & Regulation
FDA or EMA Novel Drug Approvals 2024: Anagrams Edition

December 24, 2024

1 min read

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

Celebrating a Decade in Bioprocessing
Bioprocessing - Upstream & Downstream Bioprocessing - Single Use Systems
Celebrating a Decade in Bioprocessing

November 15, 2024

1 min read

The Medicine Maker is celebrating its 10-year anniversary! We look back on some of our top articles in biopharma and bioprocessing, from X-ray sterilization for single-use systems, to supply chains for sensitive products, to making biologic...

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.